How to Select IPO to Apply in 2026: A Practical Framework for Retail Investors
By IPO Cracker Editorial Team · 17 Jun 2026
Every week in 2026, new IPOs are launching on BSE and NSE. Some get subscribed 100+ times. Others barely cross 1x. The difference between the two is not luck — it is research.
Knowing how to select IPO to apply in 2026 is one of the most useful skills a retail investor can build. This page breaks down the exact process — from reading the DRHP to checking QIB data — with real examples from IPOs that have already listed this year.
All data and examples here are sourced from official SEBI filings, BSE, NSE, and live market trackers as of June 2026.
Step 1 — Read the DRHP and RHP Before Anything Else
The Draft Red Herring Prospectus (DRHP) is the first document a company files with SEBI before its IPO. It contains the business model, financial statements for the last 3 years, risk factors, use of proceeds, and management background.
Most retail investors never open it. That is exactly why reading it gives you an edge.
You do not need to read all 300+ pages. Focus on five sections — Business Overview, Risk Factors, Financial Statements, Use of Proceeds, and Outstanding Litigations. These five sections will tell you 80% of what you need to know before deciding whether to apply.
The RHP (Red Herring Prospectus) is filed just before the IPO opens and includes the final price band. Compare the valuation in the RHP against listed sector peers before you bid.
Step 2 — Financial Health Check: Key to How to Select IPO to Apply in 2026
This is where most decisions should be made. A company's financials over the last 2–3 years tell you if the business is actually growing or if this is just a fundraise for promoters to exit.
Look at four things specifically. Revenue growth — is it consistent year on year? Profitability — is the company making money, and are margins stable? Debt levels — is the debt-to-equity ratio manageable, and is interest coverage strong? Cash flow — is operating cash flow positive even when PAT looks good?
|
Financial Metric |
What a Strong Signal Looks Like |
|
Revenue Growth |
15–20%+ consistent YoY over last 2–3 years |
|
Net Profit |
Positive and growing — not just in the IPO year |
|
EBITDA Margin |
Stable or improving — not declining into the IPO |
|
Debt-to-Equity |
Below 1x for most sectors; lower is better |
|
ROE / ROCE |
15%+ ROE and ROCE signals efficient capital use |
|
Cash Flow |
Positive operating cash flow, not just accounting profits |
A company that shows a sudden profit spike only in the year of its IPO is a red flag. Some companies time their financials to look their best right before listing. Look at the 3-year trend, not just the most recent year.
Step 3 — Compare Valuation Against Listed Peers
This step is where how to select IPO to apply in 2026 gets most investors into trouble. A strong company can still be a bad investment if the IPO is priced at 40x P/E when listed sector peers trade at 20x.
For every IPO you consider, find 2–3 directly comparable companies already listed on BSE or NSE. Pull their current P/E, EV/EBITDA, and Price-to-Book ratios. Then compare them to the IPO's implied valuation at the upper price band.
|
Ratio |
How to Use It |
|
P/E (Price to Earnings) |
Most common — compare IPO P/E vs listed peer P/E |
|
EV/EBITDA |
Better for capital-heavy businesses like manufacturing |
|
P/B (Price to Book) |
Best for financial sector — banks, NBFCs, AMCs |
|
P/S (Price to Sales) |
Use when company is pre-profit but growing fast |
If the IPO is priced at a significant premium to peers without a clear reason — faster growth, better margins, or a dominant market position — be cautious. Overpriced IPOs tend to disappoint on listing day even when the company is fundamentally sound.
Step 4 — Understand What the IPO Money Is Being Used For
The "Objects of the Issue" section in the RHP tells you exactly where the money raised from the IPO will go. This section is more important than most investors realise.
A company using IPO proceeds for capacity expansion, technology development, debt reduction, or working capital is reinvesting in the business. That is healthy. A company where the majority of the issue is an Offer for Sale (OFS) — where existing shareholders are selling their stakes — means the money goes to promoters or early investors, not to the company.
OFS is not always bad. But a 100% OFS with no fresh issue component means the company is not getting any capital from the IPO. It raises the question of why promoters are exiting now, at this valuation.
Step 5 — Track GMP Trend, Not Just the Number
Grey Market Premium (GMP) is one of the most watched signals in IPO investing in India. It reflects what the informal market is willing to pay for IPO shares before listing. But the trend matters far more than the headline number.
A GMP of ₹50 that holds steady or rises through all 3 days of subscription shows genuine informal demand. A GMP of ₹80 on Day 1 that falls to ₹20 by Day 3 tells a very different story — demand peaked early and faded, which often predicts a weaker listing.
GMP is not regulated by SEBI and carries no guarantee. Never apply to an IPO based purely on GMP without checking the company's financials and subscription data. CMR Green Technologies had a GMP of ₹66–₹70 during its June 2026 subscription and ended up subscribing 127x — GMP and fundamentals aligned there. That is the combination to look for.
Step 6 — Watch QIB and Anchor Investor Data
Qualified Institutional Buyers (QIBs) — mutual funds, FIIs, insurance companies, and banks — do serious research before they commit capital. Their subscription level is one of the strongest signals available to retail investors.
CMR Green Technologies saw 270x QIB subscription in June 2026. Hexagon Nutrition saw 19.77x QIB despite overall 53x subscription. These numbers reflect institutional conviction that is hard to fake.
Anchor investor allocation, which happens one working day before the IPO opens, is the earliest signal. A strong anchor round with reputed domestic mutual funds like SBI, HDFC, Nippon, or Mirae — or global FIIs — means the issue has passed the highest level of institutional due diligence before retail investors even see the subscription.
|
Subscription Signal |
What It Tells You |
|
QIB 5x+ |
Institutional buyers have done research and see value |
|
QIB 50x+ |
Very strong institutional conviction — rare signal |
|
NII (HNI) 10x+ |
High-net-worth investors see listing gain potential |
|
Retail 10x+ |
Strong retail demand — allotment will be by lottery |
|
Anchor Round |
Strong MF/FII names = highest credibility signal |
Step 7 — Promoter Background: Often Overlooked When Deciding How to Select IPO to Apply in 2026
A company is only as good as the people running it. The RHP has a detailed management section — read it.
Check how long the promoters have been in the business. Look for any regulatory penalties, past company failures, or legal cases mentioned in the Outstanding Litigations section. A history of multiple failed ventures or SEBI orders against promoters is a serious warning sign.
Also check promoter holding post-IPO. If promoters hold 70%+ after listing, they have skin in the game. If post-IPO promoter holding drops below 40–50%, it may indicate they are using the IPO primarily as an exit.
Real Examples from 2026
Two recent mainboard IPOs show how this framework plays out in practice.
CMR Green Technologies (June 2026) checked most boxes — established since 2006, OEM customers like Honda, Bajaj, and Maruti, consistent revenue growth, and a sector tailwind from India's push toward metal recycling. QIB subscribed 270x. It listed with a 34.4% gain over issue price.
Hexagon Nutrition (June 2026) had 30+ years of operating history, three manufacturing facilities, and a diversified product range across clinical nutrition and micronutrient premixes. It subscribed 53.48x overall with strong NII demand at 161x. It listed on June 12, 2026.
These were not random outcomes. Both companies had clear business models, verifiable financials, and strong institutional participation — the signals were there before listing.
Common Mistakes Investors Make When Learning How to Select IPO to Apply in 2026
Many retail investors lose money in IPOs not because the company was bad, but because they applied for the wrong reasons.
Applying only because of a high GMP is the most common mistake. GMP can collapse between subscription close and listing day if market sentiment shifts. Always check the fundamentals before GMP confirms your decision, not the other way around.
Applying to every IPO to improve allotment chances is another trap. Each application blocks your capital via ASBA for 6–7 days. If you apply to 5 weak IPOs at the same time, you tie up ₹70,000–₹75,000 for a week and may get allotted in the weakest one.
Never invest in an IPO money you cannot hold for 6–12 months. Not every issue delivers listing gains. A strong company bought at a fair price will eventually deliver returns — but you need the patience to hold if the listing is flat or slightly negative.
Frequently Asked Questions
-
How do I know if an IPO is overpriced before applying?
Compare the IPO's implied P/E at the upper price band against 2–3 listed companies in the same sector. If the IPO P/E is 40x and peers trade at 20–25x, the issue is priced aggressively. A premium is justified only if the company is growing meaningfully faster than its peers or has a clearly dominant market position.
-
Is GMP reliable for knowing how to select IPO to apply in 2026?
GMP is a useful supporting signal but not a standalone decision tool. A rising GMP combined with strong QIB subscription and solid fundamentals is a strong positive setup. A high GMP with weak QIB subscription and average financials is much riskier. Always use GMP alongside other data, never in isolation.
-
What sections of the RHP should I read as a retail investor?
Focus on five sections — Business Overview, Risk Factors, Financial Statements (restated), Objects of the Issue, and Basis of Issue Price. These will tell you what the company does, whether the financials are real and growing, where the IPO money is going, and whether the valuation is justified versus listed peers.
-
Does applying for more lots increase my allotment chances in a mainboard IPO?
No. In oversubscribed mainboard IPOs, SEBI mandates a lottery system where each retail applicant gets one lot or nothing — regardless of how many lots they applied for. Applying for the minimum one lot is the most capital-efficient approach for retail investors.
-
What is the difference between DRHP and RHP and which one should I read?
DRHP is filed with SEBI before the IPO and does not contain the final price band. RHP is filed just before the issue opens and includes the final price band, lot size, and subscription dates. For investment decisions, read the RHP. For early research on upcoming IPOs, the DRHP is useful even before the price band is announced.
IPO Cracker covers everything you need to know about how to select IPO to apply in 2026 — from live GMP tracking to subscription data and allotment results.
This article is for informational purposes only and does not constitute investment advice. IPO investing involves market risk. Always read the Red Herring Prospectus before investing and consult a SEBI-registered financial advisor. GMP data is unofficial and not regulated by SEBI.